Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.32 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.32 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
| ▸ | MPL | P40238 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 6/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12823065 | 0.89 | FFAR4 (0.32) | FFAR4 | |
| SCHEMBL12823393 | 0.89 | FFAR4 (0.32) | FFAR4 | |
| SCHEMBL12823256 | 0.88 | FFAR1 (0.36) | FFAR4 | |
| SCHEMBL12718399 | 0.88 | BRD4 (0.34) | — | |
| SCHEMBL12823721 | 0.87 | FFAR4 (0.37) | FFAR4 | |
| SCHEMBL12823733 | 0.87 | FFAR4 (0.36) | FFAR4 | |
| SCHEMBL12822598 | 0.86 | CYP17A1 (0.34) | RARB | |
| SCHEMBL12823897 | 0.86 | FFAR1 (0.40) | FFAR4 | |
| SCHEMBL12823673 | 0.86 | KDM1A (0.33) | — | |
| SCHEMBL12823003 | 0.85 | NUDT1 (0.33) | BACE1NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110090450-A1 | FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110090450-A1 | FOUR-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, LAS1L, EFHD2 | BACE1 1340/4885NUDT1 3921/4885RARB 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.